157 related articles for article (PubMed ID: 17405130)
21. Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters.
Yamashita A; Singh SK; Kawate T; Jin Y; Gouaux E
Nature; 2005 Sep; 437(7056):215-23. PubMed ID: 16041361
[TBL] [Abstract][Full Text] [Related]
22. Characterization of an allosteric citalopram-binding site at the serotonin transporter.
Chen F; Larsen MB; Neubauer HA; Sánchez C; Plenge P; Wiborg O
J Neurochem; 2005 Jan; 92(1):21-8. PubMed ID: 15606893
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanism of substrate specificity in the bacterial neutral amino acid transporter LeuT.
Noskov SY
Proteins; 2008 Dec; 73(4):851-63. PubMed ID: 18536011
[TBL] [Abstract][Full Text] [Related]
24. Conserved serine residues in serotonin transporter contribute to high-affinity cocaine binding.
Gu HH; Wu X; Han DD
Biochem Biophys Res Commun; 2006 May; 343(4):1179-85. PubMed ID: 16580636
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional models of neurotransmitter transporters and their interactions with cocaine and S-citalopram.
Ravna AW
World J Biol Psychiatry; 2006; 7(2):99-109. PubMed ID: 16684682
[TBL] [Abstract][Full Text] [Related]
26. Driving forces for ligand migration in the leucine transporter.
Jørgensen AM; Topiol S
Chem Biol Drug Des; 2008 Oct; 72(4):265-72. PubMed ID: 18844672
[TBL] [Abstract][Full Text] [Related]
27. Bound to be different: neurotransmitter transporters meet their bacterial cousins.
Henry LK; Meiler J; Blakely RD
Mol Interv; 2007 Dec; 7(6):306-9. PubMed ID: 18199851
[TBL] [Abstract][Full Text] [Related]
28. Emerging structure-function relationships defining monoamine NSS transporter substrate and ligand affinity.
Wang CI; Lewis RJ
Biochem Pharmacol; 2010 Apr; 79(8):1083-91. PubMed ID: 19954741
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters.
Zhang P; Cyriac G; Kopajtic T; Zhao Y; Javitch JA; Katz JL; Newman AH
J Med Chem; 2010 Aug; 53(16):6112-21. PubMed ID: 20672825
[TBL] [Abstract][Full Text] [Related]
30. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.
Andersen J; Stuhr-Hansen N; Zachariassen L; Toubro S; Hansen SM; Eildal JN; Bond AD; Bøgesø KP; Bang-Andersen B; Kristensen AS; Strømgaard K
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12137-42. PubMed ID: 21730142
[TBL] [Abstract][Full Text] [Related]
31. Engineered zinc-binding sites confirm proximity and orientation of transmembrane helices I and III in the human serotonin transporter.
White KJ; Kiser PD; Nichols DE; Barker EL
Protein Sci; 2006 Oct; 15(10):2411-22. PubMed ID: 17008722
[TBL] [Abstract][Full Text] [Related]
32. Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands.
Macdougall IJ; Griffith R
J Mol Graph Model; 2008 Apr; 26(7):1113-24. PubMed ID: 18023378
[TBL] [Abstract][Full Text] [Related]
33. The structure of Mg-ATPase nucleotide-binding domain at 1.6 A resolution reveals a unique ATP-binding motif.
Håkansson KO
Acta Crystallogr D Biol Crystallogr; 2009 Nov; 65(Pt 11):1181-6. PubMed ID: 19923713
[TBL] [Abstract][Full Text] [Related]
34. Structure and localisation of drug binding sites on neurotransmitter transporters.
Ravna AW; Sylte I; Dahl SG
J Mol Model; 2009 Oct; 15(10):1155-64. PubMed ID: 19238460
[TBL] [Abstract][Full Text] [Related]
35. Ancestry of neuronal monoamine transporters in the Metazoa.
Caveney S; Cladman W; Verellen L; Donly C
J Exp Biol; 2006 Dec; 209(Pt 24):4858-68. PubMed ID: 17142674
[TBL] [Abstract][Full Text] [Related]
36. Templates and models of monoamine transporter proteins.
Sylte I; Ravna AW; Dahl SG
Curr Med Chem; 2011; 18(30):4651-8. PubMed ID: 21864275
[TBL] [Abstract][Full Text] [Related]
37. The allosteric citalopram binding site differentially interferes with neuronal firing rate and SERT trafficking in serotonergic neurons.
Matthäus F; Haddjeri N; Sánchez C; Martí Y; Bahri S; Rovera R; Schloss P; Lau T
Eur Neuropsychopharmacol; 2016 Nov; 26(11):1806-1817. PubMed ID: 27665061
[TBL] [Abstract][Full Text] [Related]
38. Structural analysis of the extracellular entrance to the serotonin transporter permeation pathway.
Torres-Altoro MI; Kuntz CP; Nichols DE; Barker EL
J Biol Chem; 2010 May; 285(20):15369-15379. PubMed ID: 20304925
[TBL] [Abstract][Full Text] [Related]
39. Exploration of insights, opportunities and caveats provided by the X-ray structures of hSERT.
Topiol S; Bang-Andersen B; Sanchez C; Bøgesø KP
Bioorg Med Chem Lett; 2016 Oct; 26(20):5058-5064. PubMed ID: 27624075
[TBL] [Abstract][Full Text] [Related]
40. Crystallographic and functional characterization of the fluorodifen-inducible glutathione transferase from Glycine max reveals an active site topography suited for diphenylether herbicides and a novel L-site.
Axarli I; Dhavala P; Papageorgiou AC; Labrou NE
J Mol Biol; 2009 Jan; 385(3):984-1002. PubMed ID: 19014949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
